The company is currently working on expanding the BTM product range of products. An additional 510(k) submission to further support the BTM range will be submitted to the FDA later in 2023. Additional 510(k) submissions are planned for 2024.
Unfortunately, I wasn’t able to catch the webinar yesterday.
Was any further detail provided on the statement above? For example, are these submissions for new sizes or for new indications?
- Forums
- ASX - By Stock
- PNV
- Ann: Webcast Details - FY23 Results
PNV
polynovo limited
Add to My Watchlist
0.62%
!
$1.21

Ann: Webcast Details - FY23 Results, page-103
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.21 |
Change
-0.008(0.62%) |
Mkt cap ! $837.6M |
Open | High | Low | Value | Volume |
$1.22 | $1.22 | $1.19 | $1.537M | 1.282M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 3516 | $1.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.21 | 20529 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 7863 | 1.205 |
23 | 57587 | 1.200 |
12 | 68820 | 1.195 |
15 | 120044 | 1.190 |
7 | 28491 | 1.185 |
Price($) | Vol. | No. |
---|---|---|
1.210 | 20600 | 29 |
1.215 | 31977 | 22 |
1.220 | 54229 | 13 |
1.225 | 84245 | 10 |
1.230 | 18097 | 4 |
Last trade - 15.11pm 18/06/2025 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online